文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

遗传性血色素沉着症:检测与管理

Hereditary haemochromatosis: detection and management.

作者信息

Vautier G, Murray M, Olynyk J K

机构信息

Royal Defence Medical College, Gosport, UK.

出版信息

Med J Aust. 2001 Oct 15;175(8):418-21. doi: 10.5694/j.1326-5377.2001.tb143650.x.


DOI:10.5694/j.1326-5377.2001.tb143650.x
PMID:11700835
Abstract

Hereditary haemochromatosis is common, affecting one in 200 Australians of Anglo-Celtic descent; it results in iron overload affecting many organs, including the liver, heart, endocrine and musculoskeletal system. Diagnosis requires a high index of suspicion, as presenting symptoms and signs may be non-specific. Once suspected, hereditary haemochromatosis can be readily diagnosed by measurement of serum transferrin saturation and ferritin level, followed by genetic assessment. Homozygosity for the C282Y mutation in the HFE gene accounts for most cases in people of Anglo-Celtic descent in Australia; a genetic test for this mutation is widely available. Liver biopsy is advocated only in selected individuals at risk of cirrhosis or with an unclear diagnosis. Therapeutic phlebotomy remains the treatment and, if instituted early, will prevent many of the organ-specific complications.

摘要

遗传性血色素沉着症很常见,在200名英裔凯尔特血统的澳大利亚人中就有1人受其影响;它会导致铁过载,影响包括肝脏、心脏、内分泌和肌肉骨骼系统在内的许多器官。诊断需要高度的怀疑指数,因为出现的症状和体征可能不具特异性。一旦怀疑,遗传性血色素沉着症可通过测量血清转铁蛋白饱和度和铁蛋白水平,随后进行基因评估来轻松诊断。HFE基因中C282Y突变的纯合子在澳大利亚英裔凯尔特血统人群中占大多数病例;针对该突变的基因检测广泛可用。仅在有肝硬化风险或诊断不明确的特定个体中提倡进行肝活检。治疗性放血仍然是治疗方法,如果早期进行,将预防许多器官特异性并发症。

相似文献

[1]
Hereditary haemochromatosis: detection and management.

Med J Aust. 2001-10-15

[2]
Diagnosis and management of genetic haemochromatosis.

Best Pract Res Clin Haematol. 2002-6

[3]
Hereditary haemochromatosis: diagnosis and management in the gene era.

Liver. 1999-4

[4]
Review article: haemochromatosis.

Aliment Pharmacol Ther. 2002-12

[5]
[Diagnosis of 5 patients with possible primary hemochromatosis].

Ned Tijdschr Geneeskd. 2003-4-5

[6]
Hereditary hemochromatosis: pathophysiology, diagnosis, and management.

Crit Care Nurs Clin North Am. 2008-6

[7]
Testing for haemochromatosis in a liver clinic population: relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers.

Eur J Gastroenterol Hepatol. 2002-3

[8]
Hereditary hemochromatosis.

Am Fam Physician. 2013-2-1

[9]
Review article: the screening, diagnosis and optimal management of haemochromatosis.

Aliment Pharmacol Ther. 1997-8

[10]
Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.

Lancet Gastroenterol Hepatol. 2023-12

引用本文的文献

[1]
Changes in exercise capacity in subjects with cardiac asymptomatic hereditary hemochromatosis during a follow-up after 5 yrs.

Am J Phys Med Rehabil. 2012-5

[2]
Normal iron metabolism and the pathophysiology of iron overload disorders.

Clin Biochem Rev. 2006-2

[3]
Screening for hemochromatosis: patients with liver disease, families, and populations.

Curr Gastroenterol Rep. 2004-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索